1.Construction and identification of an apoptosis detection system based on firefly luciferase reporter gene.
Luping CHE ; Yonghua LI ; Bin YANG ; Zhikai XU ; Ying LIAO ; Xusheng QIU ; Lei TAN ; Yingjie SUN ; Cuiping SONG ; Chan DING ; Gang YAO ; Jinquan WANG ; Chunchun MENG
Chinese Journal of Biotechnology 2019;35(8):1557-1565
To construct a eukaryotic expression plasmid containing the luciferase reporter gene (Fluc) to quickly detect apoptosis. Four amino acids, Asp-Glu-Val-Asp (DEVD), the recognize motif of Caspase-3, were introduced into the middle of the Fluc-C and N fragment. Meanwhile, four amino acids, Asp-Glu-Val-Gly (DEVG), were selected as a negative control. Subsequently, the recombinant gene was cloned into the N and C terminal end of the split intein, and named as pFluc-DEVD and pFluc-DEVG. Then the plasmids were transfected into cells and renilla luciferase was co-transfected in each sample as an internal control for transfection efficiency. Then the apoptosis level was detected by the double luciferase reporter gene and the Western blotting analysis. The results showed that when apoptosis occurred, the content of firefly luciferase expressed in the pFluc-DEVD plasmid transfected group was about 3 times higher than pFluc-DEVG plasmid transfected group. Furthermore, Western blotting detection indicated that the Fluc level was significantly increased in pFluc-DEVD transfected group when pre-treated by apoptosis stimulants. The activation degree of Caspase-3 was closely related to the expression of Fluc, and had a significant statistical difference. These results confirmed that firefly luciferase protein expressed by pFluc-DEVD plasmid can be cleaved by the intracellular Caspase-3 enzyme, and this plasmid can accurately reflect the cell apoptosis level, which provides a useful method for quantitative detection of apoptosis.
Apoptosis
;
Genes, Reporter
;
Luciferases, Firefly
;
Transfection
2.Reconstruction and preparation of lentiviral vector system expressing dual-reporter genes.
Chen LI ; Bin ZHANG ; Jun WANG ; Wei-Xia KONG ; Rui-Ping WANG ; Ting LIU ; Hu CHEN
Journal of Experimental Hematology 2011;19(6):1489-1492
This study was aimed to construct, package and purify the recombinant lentivirus vector carrying the firefly luciferase gene (FLUC) and red fluorescent protein gene (RFP) and to transfect the recombinant lentivirus into HeLa cells, so as to observe the expression levels of these two genes. The FLUC and RFP genes were amplified by RT-PCR and inserted in the lentiviral expression vector (pLenti-Bi-cistronic) to construct the lentiviral vector pLenti-FLUC-RFP. The viral particles were generated by cotransfection of 293T cells with pLenti-FLUC-RFP and three packaging vectors, and the virus titer was determined by calculating the percentage of RFP positive cells. After transfection of pLenti-FLUC-RFP into HeLa cells, the expression of RFP was observed by fluorescent microscopy, and the activity of FLUC was determined by luciferase reporter gene assay kit. The results showed that the inserting orientation of the RFP and FLUC genes in the lentiviral vector pLenti-FLUC-RFP were verified by restriction analysis. Targeted RFP and FLUC sequences were confirmed by DNA sequencing. The final titer obtained was 1×10(7)TU/ml. The expressions of RFP and FLUC were observed in the transfected HeLa cells. It is concluded that the pLenti-III-FLUC-RFP recombinant lentivirus vector carrying RFP gene and FLUC gene with high viral titer is constructed and packaged successfully, and provides experimental basis for studying dynamic distribution of mesenchymal stem cells in vivo.
Gene Expression
;
Genes, Reporter
;
Genetic Vectors
;
HeLa Cells
;
Humans
;
Lentivirus
;
genetics
;
Luciferases, Firefly
;
genetics
;
Luminescent Proteins
;
genetics
;
Transfection
3.Bioluminescent imaging monitoring of a anti-angiogenesis therapeutic gene vasostatin in tumor cell PC3.
Jie-miao HU ; Fei-chan QIU ; Bin YIN ; Yan-hua GONG ; Jian-gang YUAN ; Bo-qin QIANG ; Shi-zhen WANG ; Xiao-zhong PENG
Acta Academiae Medicinae Sinicae 2007;29(3):312-317
OBJECTIVETo generate a sensitive tool for noninvasive monitoring of a therapeutic gene vasostatin.
METHODSWe fused the bioluminescent reporter gene firefly luciferase to the therapeutic transgene vasostatin and ensured that these two proteins would not interrupt each other and kept their own natural character.
RESULTSWe therefore examined clones of PC3 cells stably expressing fusion gene and positive controlfluc with bioluminescence. In vivo imaging of PC3-Fluc subcutaneous tumors showed that the mean tumor bioluminescence increased in animals over several weeks.
CONCLUSIONNoninvasive monitoring facilitates the detection of gene expression in vivo and in vitro.
Animals ; Calreticulin ; genetics ; metabolism ; Cell Line, Tumor ; Gene Transfer Techniques ; Genes, Reporter ; Humans ; Luciferases, Firefly ; genetics ; metabolism ; Luminescent Measurements ; Neoplasm Transplantation ; Peptide Fragments ; genetics ; metabolism ; Recombinant Fusion Proteins ; genetics ; metabolism
4.Construction and identification of recombinant firefly luciferase report vector containing human acyl coenzyme a: cholesterol acyltransferase 1 gene P7 promoter.
Jing GE ; Bei CHENG ; Ping HE ; Hui WEN ; Han LU ; Xin CHEN ; Yongli ZENG
Journal of Biomedical Engineering 2008;25(6):1381-1384
The DNA segment of the human acyl coenzyme A: cholesterol acyltransferasel (ACAT1) gene P7 promoter was amplified by PCR from human monocytic leukemia cell line (THP-1) and cloned to TA vector, then the positive clone was confirmed by restriction enzymes and sequencing. The targeted segment was subcloned to Firefly luciferase report vector pGL3-Enhancer. The recombinant plasmid pGL3E-P7 was transfected transiently into THP-1, then the expression of luciferase could be detected in THP-1 by pGL3E-P7 transfection. We successfully constructed luciferase reporter vector containing P7 promoter of the human ACAT1 gene, and established a new means to study the transcriptional regulation mechanisms of ACAT1 during atherosclerosis.
Cell Line, Tumor
;
Chromosomes, Human, Pair 7
;
genetics
;
Gene Expression Regulation
;
Genes, Reporter
;
genetics
;
Genetic Vectors
;
genetics
;
Humans
;
Leukemia, Monocytic, Acute
;
pathology
;
Luciferases, Firefly
;
genetics
;
metabolism
;
RNA, Messenger
;
genetics
;
metabolism
;
Recombinant Proteins
;
genetics
;
metabolism
;
Sterol O-Acyltransferase
;
genetics
;
metabolism
;
Transfection
5.Heterologous genes expression on Escherichia coli chromosome lac operon using Red recombination.
Shanhu LI ; Qingguo SHI ; Cuifen HUANG ; Jianguang ZHOU
Chinese Journal of Biotechnology 2008;24(4):576-580
To achieve efficient and stable expression of heterologous exogenetic protein or antigen in E. coli chromosome, the luciferase report gene was knocked in lacZ site of chromosome lac operon by using Red recombination system and selection-counterselection kan/sacB technology. The quantitative analysis of exogenous gene expression indicated that the target gene could be efficiently expressed at lacZ site of lac operon. The results confirmed the efficient screening and stable expression of heterologous protein or antigen on chromosome by using the recombinant engineering technique. This study demonstrated that the chromosome could be used as a vector for heterologous protein or antigen and the stable expression of exogenous gene on E. coli chromosome had no side effect on the bacterial growth and propagation.
Bacteriophage lambda
;
genetics
;
Chromosomes, Bacterial
;
genetics
;
Cloning, Molecular
;
Escherichia coli
;
genetics
;
metabolism
;
Gene Knock-In Techniques
;
methods
;
Genes, Reporter
;
genetics
;
Lac Operon
;
genetics
;
Luciferases
;
genetics
;
Recombination, Genetic
;
genetics
6.Establishment of an Orthotopic Mouse Non-Muscle Invasive Bladder Cancer Model Expressing the Mammalian Target of Rapamycin Signaling Pathway.
Soon Ja KIM ; Ho Kyung SEO ; Hye Hyun SEO ; Sang Jin LEE ; Jong Kyou KWON ; Tae Jin LEE ; Byung Hoon CHI ; In Ho CHANG
Journal of Korean Medical Science 2014;29(3):343-350
We established an orthotopic non-muscle invasive bladder cancer (NMIBC) mouse model expressing the mammalian target of the rapamycin (mTOR) signaling pathway. After intravesical instillation of KU-7-lucs (day 0), animals were subsequently monitored by bioluminescence imaging (BLI) on days 4, 7, 14, and 21, and performed histopathological examination. We also validated the orthotopic mouse model expressing the mTOR signaling pathway immunohistochemically. In vitro BLI photon density was correlated with KU-7-luc cell number (r2 = 0.97, P < 0.01) and in vivo BLI photon densities increased steadily with time after intravesical instillation. The tumor take rate was 84.2%, formed initially on day 4 and remained NMIBC up to day 21. T1 photon densities were significantly higher than Ta (P < 0.01), and histological tumor volume was positively correlated with BLI photon density (r2 = 0.87, P < 0.01). The mTOR signaling pathway-related proteins were expressed in the bladder, and were correlated with the western blot results. Our results suggest successful establishment of an orthotopic mouse NMIBC model expressing the mTOR signaling pathway using KU-7-luc cells. This model is expected to be helpful to evaluate preclinical testing of intravesical therapy based on the mTOR signaling pathway against NMIBC.
Animals
;
Blotting, Western
;
Cell Line, Tumor
;
Disease Models, Animal
;
Female
;
Genes, Reporter
;
Green Fluorescent Proteins/genetics/metabolism
;
Humans
;
Immunohistochemistry
;
Luciferases, Firefly/genetics
;
Luminescent Measurements
;
Mice
;
Mice, Nude
;
Neoplasm Staging
;
*Signal Transduction
;
TOR Serine-Threonine Kinases/*metabolism
;
Transplantation, Heterologous
;
Urinary Bladder Neoplasms/*metabolism/pathology/veterinary
7.Long-term and stable correction of uremic anemia by intramuscular injection of plasmids containing hypoxia-regulated system of erythropoietin expression.
Jifeng SUN ; Yarong WANG ; Jie YANG ; Dewei DU ; Zhanting LI ; Junxia WEI ; Angang YANG
Experimental & Molecular Medicine 2012;44(11):674-683
Relative deficiency in production of glycoprotein hormone erythropoietin (Epo) is a major cause of renal anemia. This study planned to investigate whether the hypoxia-regulated system of Epo expression, constructed by fusing Epo gene to the chimeric phosphoglycerate kinase (PGK) hypoxia response elements (HRE) in combination with cytomegalovirus immediate-early (CMV IE) basal gene promoter and delivered by plasmid intramuscular injection, might provide a long-term physiologically regulated Epo secretion expression to correct the anemia in adenine-induced uremic rats. Plasmid vectors (pHRE-Epo) were synthesized by fusing human Epo cDNA to the HRE/CMV promoter. Hypoxia-inducible activity of this promoter was evaluated first in vitro and then in vivo in healthy and uremic rats (n = 30 per group). The vectors (pCMV-Epo) in which Epo expression was directed by a constitutive CMV gene promoter served as control. ANOVA and Student's t-test were used to analyze between-group differences. A high-level expression of Epo was induced by hypoxia in vitro and in vivo. Though both pHRE-Epo and pCMV-Epo corrected anemia, the hematocrit of the pCMV-Epo-treated rats exceeded the normal (P < 0.05), but that of the pHRE-Epo-treated rats didn't. Hypoxia-regulated system of Epo gene expression constructed by fusing Epo to the HRE/CMV promoter and delivered by plasmid intramuscular injection may provide a long-term and stable Epo expression and secretion in vivo to correct the anemia in adenine-induced uremic rats.
Anemia/blood/*therapy
;
Animals
;
Base Sequence
;
Blood Urea Nitrogen
;
Cell Hypoxia
;
Creatinine/blood
;
Erythropoietin/biosynthesis/*genetics/secretion
;
Gene Expression Regulation
;
Genes, Reporter
;
Genetic Therapy
;
HeLa Cells
;
Humans
;
Injections, Intramuscular
;
Kidney/pathology
;
Luciferases, Firefly/biosynthesis/genetics
;
Molecular Sequence Data
;
Plasmids/*genetics
;
Promoter Regions, Genetic
;
Rats
;
Rats, Sprague-Dawley
;
Recombinant Proteins/biosynthesis/genetics/secretion
;
Response Elements
;
Transcriptional Activation
;
Uremia/blood/*therapy
8.Protein Kinase C-alpha Regulates Toll-like Receptor 4-Mediated Inducible Nitric Oxide Synthase Expression.
Jin Gu LEE ; Byung Rho CHIN ; Suk Hwan BAEK
Journal of the Korean Association of Oral and Maxillofacial Surgeons 2008;34(1):28-35
PURPOSE: The nitric oxide (NO) release by inducible nitric oxide synthase (iNOS) is the key events in macrophage response to lipopolysaccharide (LPS) which is suggested to be a crucial mediator for inflammatory and innate immune responses. NO is an important mediator involved in many host defense action and may also lead to a harmful host response to bacterial infection. However, given the importance of iNOS in a variety of pathophysiological conditions, control of its expression and signaling events in response to LPS has been the subject of considerable investigation. MATERIALS AND METHODS: The Raw264.7 macrophage cell line was used to observe LPS-stimulated iNOS expression. The expression of iNOS is observed by Western blot analysis and real-time RT-PCR. Protein kinase C (PKC)-alpha overexpressing Raw264.7 cells are established to determine the involvement of PKC-alpha in LPS-mediated iNOS expression. NF-kappaB activity is measured by IkappaBalpha degradation and NF-kappaB luciferase activity assay. RESULTS: We found that various PKC isozymes regulate LPS-induced iNOS expression at the transcriptional and translational levels. The involvement of PKC-alpha in LPS-mediated iNOS induction was further confirmed by increased iNOS expression in PKC-alpha overexpressing cells. NF-kappaB dependent transactivation by LPS was observed and PKC-alpha specific inhibitory peptide abolished this activation, indicating that NF-kappaB activation is dependent on PKC-alpha. CONCLUSION: Our data suggests that PKC-alpha is involved in LPS-mediated iNOS expression and that its downstream target is NF-kappaB. Although PKC-alpha is a crucial mediator in the iNOS regulation, other PKC isozymes may contribute LPS-stimulated iNOS expression. This finding is needed to be elucidated in further study.
Bacterial Infections
;
Blotting, Western
;
Cell Line
;
I-kappa B Proteins
;
Immunity, Innate
;
Isoenzymes
;
Luciferases
;
Macrophages
;
NF-kappa B
;
Nitric Oxide
;
Nitric Oxide Synthase Type II
;
Protein Kinase C
;
Protein Kinase C-alpha
;
Protein Kinases
;
Toll-Like Receptors
;
Transcriptional Activation
9.TGF - beta Type II Receptor Anomaly and of Its Functional Restoration in Osteosarcoma Cell Lines.
Kwan Hee LEE ; Sang Soo OH ; Young Deog CHA ; Suk Myun KO ; In Suk OH ; Joung Yoon LEE ; Sung Jin KIM
The Journal of the Korean Orthopaedic Association 1998;33(3):914-919
TGF-p receptor mutation is now considered as one of the carcinogenic process of many tumors. To evaluate whether there is an abnormality in TGF-p type II receptor in osteosarcoma cell lines, we performed Northern analysis, cross-linking assay, luciferase activity and TGF-p growth inhibition assay in four osteosarcoma cell lines: G292, U202, HOS and SaOS. We also transfected the tumor cells with normal TGF-p type II receptor sequence to find if there is a possibility of gene therapy in osteosarcoma. In Northern analysis, Type II receptor expressions were decreased at SaOS, U202 and HOS cell lines. In cross-linking assay, all four cell lines didnt show type II receptor at their cell surface. The growth of these tumor cells were not suppressed by TGF-p. From these findings, we concluded that the normal production of TGF-p type II receptor was impaired in osteosarcoma. The transfection of these tumor cells with normal type II receptor sequence restored growth inhibition by TGF-p. This means even though TGF-p type II receptor is abnormal in osteosarcoma, we can restore its function by transfection of normal sequence. We think that the TGF-p type Il receptor gene therapy can be one of the treatment method for osteosarcoma in the future.
Cell Line*
;
Genetic Therapy
;
Luciferases
;
Osteosarcoma*
;
Transfection
10.Cholesterol conjugated spermine as a delivery modality of antisense oligonucleotide.
Yoon Kyung IM ; Myung Su KIM ; Hoon YOO
International Journal of Oral Biology 2013;38(4):155-160
The major issue in the development of nucleic acid based therapeutics is the inefficient delivery of these agents into cells. We prepared cholesterol conjugated spermine and evaluated its usefulness as a delivery modality for antisense oligonucleotides in HeLa-Luc cells. A 2'-O-methyl antisense oligonucleotide sequence, designed to correct splicing at an aberrant intron inserted into a normal luciferase reporter gene, was used for complex formation with cholesterol conjugated spermine. Effective delivery of this antisense agent into nucleus would results in the expression of a luciferasereporter gene product. The cholesterol-spermine formed stable complexes with the antisense oligonucleotide and showed modest delivery activity. Furthermore, this delivery activity was maintained even in the presence of serum proteins, mimicking in vivo conditions. Cholesterol-spermine thus has potential as a delivery system for antisense oligonucleotides into cells.
Blood Proteins
;
Cholesterol*
;
Genes, Reporter
;
Introns
;
Luciferases
;
Oligonucleotides, Antisense
;
Spermine*